Related Experiment Video
Updated: Jul 16, 2026

Extended 78% Hepatectomy in a Mouse Surgical Model
Published on: May 24, 2024
Gamma glutamyltransferase and long-term survival: is it just the liver?
Lili Kazemi-Shirazi1, Georg Endler, Stefan Winkler
1Institute of Medical and Chemical Laboratory Diagnostics, Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria.
Insights
Elevated gamma glutamyltransferase (GGT) levels are linked to increased all-cause mortality in both men and women, particularly in younger individuals. Even high-normal GGT indicates a significant risk for death.
Area of Science:
- Biochemistry
- Clinical Medicine
- Epidemiology
Background:
- Elevated gamma glutamyltransferase (GGT) is a known risk factor for cardiovascular disease.
- Limited large-scale studies have explored the association between GGT and all-cause mortality.
Purpose of the Study:
- To investigate the relationship between GGT levels and the risk of all-cause mortality.
- To determine if GGT is a predictor of mortality across different age groups.
Main Methods:
- A cohort study of 283,438 hospital patients with GGT analysis was conducted.
- Patients were monitored for up to 13 years.
- Cox proportional hazards models, adjusted for age and sex, were used to evaluate GGT as a predictor.
Main Results:
- GGT levels above reference ranges were significantly associated with all-cause, cancer, hepatobiliary, and vascular mortality in both sexes (P <0.001).
- Hazard ratios for mortality were similar between men and women.
- Younger patients (<30 years) with elevated GGT exhibited higher all-cause mortality rates compared to older individuals.
Conclusions:
- Gamma glutamyltransferase (GGT) is a significant predictor of mortality in both men and women.
- Elevated GGT, even within high-normal ranges, is a risk factor for all-cause mortality.
- The association between GGT and mortality is particularly pronounced in younger individuals (<30 years).
Background:
Increased gamma glutamyltransferase (GGT) is associated with cardiovascular disease. To date, however, few studies with sufficient sample size and follow-up have investigated the association of GGT with all-cause mortality.
Methods:
The relation of GGT to the risk of death was examined in a cohort of 283 438 first attendants (inpatients or outpatients) of the Vienna General Hospital with request for GGT analysis as part of a routine screening panel and was monitored for up to 13 years. To evaluate GGT as a predictor, Cox proportional hazards models were calculated, which were adjusted for age and sex.
Results:
In both men and women, GGT above the reference category (GGT > or = 9 U/L in women, > or = 14 U/L in men) was significantly (P <0.001) associated with all-cause, cancer, hepatobiliary, and vascular mortalities. Hazard ratios (HRs) for men and women were similar in all categories. Among patients who presented with GGT above the reference category, those younger than 30 years had higher all-cause mortality rates than did older individuals (HR 1.5-3.3 vs HR 1-1.3 >80 years, respectively).
Conclusions:
GGT is associated with mortality in both men and women, especially in patients younger than 30 years, and even high-normal GGT is a risk factor for all-cause mortality.
Related Concept Videos
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

